NurExone Biologic (J90) Q4 2023 Earnings Report
DE:J90 Q4 2023 EPS Results
- Actual EPS
- -EUR 0.01
- Consensus EPS
- -EUR 0.02
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- -EUR 0.02
DE:J90 Q4 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 04/02/2024
- Time
- Before Open
- Conference Call
- Tuesday, April 2, 2024
DE:J90 Upcoming Earnings
NurExone Biologic's next earnings date is estimated for November 20, 2026, based on past reporting schedules.
Q4 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:J90 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 20, 2026 | 2026 (Q3) | ―- | -0.02 | ― | ― |
| Aug 31, 2026 | 2026 (Q2) | -0.020.02 | -0.02 | 183.33% (+0.04) | |
| Jun 03, 2026 | 2026 (Q1) | ―- | -0.02 | ― | |
| Apr 16, 2026 | 2025 (Q4) | -0.02-0.02 | -0.01 | -35.00% (-0.00) | |
| Nov 26, 2025 | 2025 (Q3) | -0.02-0.02 | -0.02 | 0.00% (+0.00) | |
| Aug 27, 2025 | 2025 (Q2) | -0.02-0.02 | -0.04 | 40.00% (+0.01) | |
| May 27, 2025 | 2025 (Q1) | ―-0.01 | -0.01 | 9.09% (+0.00) | |
| Apr 09, 2025 | 2024 (Q4) | -0.02-0.02 | -0.01 | -100.00% (-0.01) | |
| Nov 27, 2024 | 2024 (Q3) | -0.03-0.02 | -0.03 | 33.33% (+0.01) | |
| Aug 28, 2024 | 2024 (Q2) | -0.02-0.04 | -0.02 | -100.00% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
